We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INDT
2551
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $452K | ﹤0.01% |
5,575
+2,276
| +69% | +$165K |
|
2552
Astronics
ATRO
$3.84B
| $451K | ﹤0.01% |
45,074
-80
| -0.2% | -$840 |
|
|
FREE
2553
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $451K | ﹤0.01% |
41,991
-679
| -2% | -$7.79K |
|
|
DSKE
2554
DELISTED
Daseke, Inc. Common Stock
DSKE
| $447K | ﹤0.01% |
44,532
-788
| -2% | -$7.75K |
|
|
CTLP
2555
DELISTED
Cantaloupe
CTLP
| $446K | ﹤0.01% |
50,207
-574
| -1% | -$5.71K |
|
2556
NWPX Infrastructure Inc
NWPX
$1.15B
| $446K | ﹤0.01% |
14,034
-151
| -1% | -$4.16K |
|
|
VBIV
2557
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $446K | ﹤0.01% |
6,351
-115
| -2% | -$9.69K |
|
2558
Foghorn Therapeutics
FHTX
$360M
| $445K | ﹤0.01% |
19,453
+979
| +5% | +$14.1K |
|
|
BRT
2559
BRT Apartments
BRT
$271M
| $444K | ﹤0.01% |
18,504
-148
| -0.8% | -$2.96K |
|
|
GNTY
2560
DELISTED
Guaranty Bancshares
GNTY
| $444K | ﹤0.01% |
11,803
-217
| -2% | -$8.16K |
|
2561
Acacia Research
ACTG
$470M
| $443K | ﹤0.01% |
86,358
+179
| +0.2% | +$966 |
|
2562
Allient
ALNT
$1.92B
| $443K | ﹤0.01% |
12,139
-311
| -2% | -$11.5K |
|
2563
Forestar Group
FOR
$1.51B
| $443K | ﹤0.01% |
20,361
-629
| -3% | -$13K |
|
2564
Altimmune
ALT
$599M
| $441K | ﹤0.01% |
48,140
+1,958
| +4% | +$20.8K |
|
2565
N-able
NABL
$940M
| $441K | ﹤0.01% |
39,707
+603
| +2% | +$7.46K |
|
2566
Lifecore Biomedical
LFCR
$190M
| $439K | ﹤0.01% |
39,530
-59
| -0.1% | -$573 |
|
|
SPNE
2567
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $439K | ﹤0.01% |
32,244
-857
| -3% | -$12.3K |
|
|
PRVB
2568
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $436K | ﹤0.01% |
77,666
+351
| +0.5% | +$2.23K |
|
2569
Annexon
ANNX
$886M
| $434K | ﹤0.01% |
37,775
-506
| -1% | -$8.18K |
|
2570
Stoke Therapeutics
STOK
$2.11B
| $431K | ﹤0.01% |
17,983
-336
| -2% | -$8.02K |
|
|
GAN
2571
DELISTED
GAN Ltd
GAN
| $430K | ﹤0.01% |
46,837
-729
| -2% | -$8.92K |
|
2572
Lindblad Expeditions
LIND
$2.22B
| $430K | ﹤0.01% |
27,565
+133
| +0.5% | +$2.1K |
|
|
BCOV
2573
DELISTED
Brightcove, Inc.
BCOV
| $429K | ﹤0.01% |
41,988
-917
| -2% | -$9.67K |
|
|
DFTX
2574
Definium Therapeutics
DFTX
$6.12B
| $428K | ﹤0.01% |
20,663
+183
| +0.9% | +$5.84K |
|
2575
Willdan Group
WLDN
$1.3B
| $426K | ﹤0.01% |
12,103
-232
| -2% | -$8.65K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.